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Oct4 plays an essential role in maintaining the inner cell mass and pluripotence of embryonic stem (ES)
cells. The expression of Oct4 is regulated by the proximal enhancer and promoter in the epiblast and by the
distal enhancer and promoter at all other stages in the pluripotent cell lineage. Here we report that the orphan
nuclear receptor LRH-1, which is expressed in undifferentiated ES cells, can bind to SF-1 response elements
in the proximal promoter and proximal enhancer of the Oct4 gene and activate Oct4 reporter gene expression.
LRH-1 is colocalized with Oct4 in the inner cell mass and the epiblast of embryos at early developmental
stages. Disruption of the LRH-1 gene results in loss of Oct4 expression at the epiblast stage and early embryonic
death. Using LRH-1/ ES cells, we also show that LRH-1 is required to maintain Oct4 expression at early
differentiation time points. In vitro and in vivo results show that LRH-1 plays an essential role in the
maintenance of Oct4 expression in ES cells at the epiblast stage of embryonic development, thereby maintain-
ing pluripotence at this crucial developmental stage prior to segregation of the primordial germ cell lineage at
gastrulation.
Pluripotence in embryonic stem (ES) cells and the early
mouse embryo is controlled by several key transcription factors
such as Oct4, Sox2, Foxd3, Nanog, and signaling molecules
such as STAT3, FGF4, FGF4 receptor, and LIF (4, 11, 18, 22,
32, 35, 51). The regulation of expression of these key factors is
thus crucial for the maintenance of pluripotence and embry-
onic development. However, little is known about the up-
stream factors that regulate the expression of these genes.
Oct4, a member of the POU homeodomain family of transcrip-
tion factors, is the best studied of these factors. Recent studies
have shown that Oct4 plays a critical role in embryonic devel-
opment and cellular differentiation (38, 43). Oct4 is expressed
in totipotent and pluripotent stem cells of the pregastrulation
embryo, primordial germ cells, and oocytes (37, 44, 47). Oct4 is
also highly expressed in ES and embryonic carcinoma cell lines,
such as P19 and F9 cells, and is rapidly down-regulated by
differentiation induced with retinoic acid (RA) (6, 31). In ES
cells, a less than twofold increase in the level of Oct4 mRNA
causes the cells to differentiate into primitive endoderm and
mesoderm, whereas reduction to less than 50% of normal
levels triggers differentiation into trophectoderm (36). More-
over, targeted disruption of the Oct4 gene in mice results in
embryonic death at the blastocyst stage and compacted morula
cells that do not differentiate along the pluripotent inner cell
mass lineage but instead differentiate into trophectodem (32).
Thus, the level of Oct4 expression is crucial not only to the
maintenance of pluripotence but also to early cell differentia-
tion decisions (36).
Previous studies have shown that several members of the
nuclear receptor family, including SF-1, GCNF, RAR/RXR,
and COUP TF I/II, regulate Oct4 expression by binding to its
proximal promoter region (5, 6, 19, 42, 49). In addition to the
proximal promoter (PP), the proximal enhancer (PE) of the
Oct4 regulatory region is essential for expression of the Oct4
gene (56). The PE is specifically activated at the epiblast stage
of embryonic development. In contrast, the distal enhancer
(DE) is active in the blastocyst and the germ line (31, 56).
However, it is not known which transcription factors are in-
volved in the regulation of Oct4 expression through these dif-
ferent enhancers.
Of the nuclear receptors implicated in the regulation of
Oct4, germ cell nuclear receptor (GCNF; NR6A1) is the best
validated. The repression function of GCNF on the Oct4 pro-
moter is driven by binding of GCNF to a DR0 element located
in the Oct4 PP (19). In GCNF/ embryos, Oct4 expression is
not repressed efficiently in somatic cells and thus is no longer
restricted to primordial germ cells after gastrulation, and the
embryos die around embryonic day 10.5 (E10.5) (12, 19).
The DR0 motif within the Oct4 promoter is also a binding
site for the orphan nuclear receptor steroidogenic factor 1
(SF-1; NR5A1). SF-1 is expressed in P19 cells and activates
Oct4 expression (5). On treatment of P19 cells with RA, SF-1
expression is decreased to undetectable levels. SF-1 knockout
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mice lack adrenal glands and gonads and die due to adrenal
insufficiency within the first week of birth (30, 46). Comparison
of SF-1 and Oct4 knockout mouse models suggests that al-
though SF-1 can regulate Oct4 expression in P19 cells, it is
essential only during late organogenesis and thus there must be
another factor that regulates Oct4 expression during early em-
bryogenesis.
The orphan nuclear receptor liver receptor homologue 1
(LRH-1; NR5A2), also termed fetoprotein transcription factor
(FTF), is closely related to SF-1, particularly in the DNA-
binding domain, and has the same DNA response element as
SF-1 (34). SF-1 and LRH-1 are differentially expressed in the
ovary (15, 23) and activate the transcription of genes encoding
steroidogenic enzymes (50). LRH-1 is expressed in endoderm-
derived tissues such as the liver, pancreas, and intestine in the
adult and developing embryos (2, 34, 45) and is involved in
regulating bile acid metabolism (13, 16, 48). Recently, LRH-1
and -catenin have been shown to synergistically regulate in-
testinal cell proliferation through cyclin G1 (9). Inactivation of
the LRH-1 gene results in early embryonic death in part due to
misregulation of endodermal genes (9, 13, 39). All of these
studies focused on the function of LRH-1 in endoderm devel-
opment and gene regulation. However, LRH-1 is also ex-
pressed in the morula and inner cell mass and the LRH-1/
embryos died at early stages (E6.5 to 7.5) (39). The similar
DNA-binding properties and complementary expression pat-
terns between SF-1 and LRH-1 suggest that LRH-1 may reg-
ulate Oct4 expression during early embryonic development and
in ES cells similar to SF-1-dependent regulation of Oct4 ex-
pression in P19 cells (5, 19).
In this study, we demonstrate that LRH-1 binds directly to
response elements located in the PP and PE of the Oct4 gene
and activates Oct4 reporter gene expression. We also show that
the expression pattern of LRH-1 in ES cells and early embry-
onic development stages overlaps with Oct4 expression. More-
over, targeted inactivation of the LRH-1 gene results in em-
bryonic death around E6.5, loss of Oct4 gene expression at the
epiblast stage of development, and more rapid down-regula-
tion of the Oct4 gene in LRH-1/ ES cells on differentiation.
These results demonstrate that LRH-1 plays an important role
in the regulation of Oct4 gene expression and pluripotence in
ES cells at the epiblast stage of embryonic development.
MATERIALS AND METHODS
Plasmids and antibodies. The mouse SF-1 expression plasmids T7-Myc-SF-1
and pCEP4SF-1 were provided by David Moore. The full-length cDNA of mouse
LRH-1 was obtained by reverse transcription-PCR from undifferentiated ES cell
total RNA. The sequence of PCR primers used are 5CAAGAATTTCCGCTA
AGAATGTCTGAG 3 (the forward primer) and 5AGTAACTTCCAGGG
GTGC 3 (the reverse primer). For mammalian expression and in vitro transla-
tion, plasmids pHA-mLRH-1 and pGBK-mLRH-1 were generated by insertion
of mLRH-1 cDNA into pCMV-HA and pGBK-T7 (Clontech, Sparks, Md.),
respectively. The Oct4 luciferase reporter vectors have been described previously
(19). The Oct4 reporter PP-Luc contains a 0.4-kb XbaI-BanI fragment from the
proximal-promoter region, and PP* is identical to PP except for the point mu-
tations inserted in the DR0 element (19). The reporter PE-PP-Luc contains a
1.2-kb BamHI-BanI fragment from the Oct4 promoter region, and PE-PP* is
identical to PE-PP except for the insertion of point mutations in the DR0
element (19). PE-SV40-Luc was constructed by the insertion of a 0.8-kb BamHI-
XbaI PE fragment of the Oct4 enhancer into pGL3-SV40-Luc (Promega, Mad-
ison, Wis.). Anti-mSF-1 antibody was purchased from Upstate (Charlottesville,
Va.; catalog no. 13702). Anti-Oct4 (no. 8628) and anti-actin (no. sc-1616) anti-
bodies and all of the horseradish peroxidase-conjugated secondary antibodies
were purchased from Santa Cruz Biotechnology (Santa Cruz, Calif.). The anti-
mouse LRH-1 antibody used in Western blot analysis and supershift assays,
which was produced in our laboratory, was raised specifically against the N
terminus of the recombinant LRH-1 mouse protein expressed in bacteria. The
portion of the LRH-1 cDNA encoding the N-terminal 100 amino acids was
inserted into a His-tagged bacterial expression vector, pRSET-A (Invitrogen,
Carlsbad, Calif.).
Cell culture and transient transfection. P19 cells and COS-1 cells were main-
tained in Dulbecco’s medium supplemented with 10% fetal calf serum. Wild-type
and LRH-1/ ES cells were maintained on 0.1% gelatin-coated plates in Dul-
becco’s medium supplemented with 15% fetal calf serum, 110 M 2-mercapo-
ethanol, 1,000 U of recombinant murine leukemia inhibitory factor (LIF; Chemi-
con, Temecula, Calif.), 100 U per ml, of penicillin per ml, and 100 g of
streptomycin per ml. For reverse transcription-PCR using differentiated P19 and
ES cells, cells were differentiated with 1 M RA in the absence of LIF and
harvested at the indicated times. For Northern blot analysis using differentiated
ES cells, wild-type or LRH-1/ ES cells were cultured on 1% gelatin-coated
bacterial plates in the absence of LIF. Cells were harvested on the indicated days,
and RNA was isolated. Day 0 cells were harvested 24 h after seeding. All the
transient transfections were performed with Fugene 6 as specified by the man-
ufacturer (Roche, Indianapolis, Ind.). The expression vector and reporter DNA
were cotransfected into P19 cells plated in six-well plates (2  105 cells per well)
for 24 h prior to transfection. The Renilla RL-Luc reporter (Promega) DNA was
also cotransfected as an internal control to correct for differences in transfection
efficiency. Total plasmid DNAs were balanced with empty vector pCMV-HA.
After 48 h of incubation, the cells were harvested and the luciferase activity was
analyzed using the dual-luciferase assay kit (Promega) as specified by the man-
ufacturer.
Electrophoretic mobility shift assays. In vitro- translated mLRH-1 and mSF-1
were produced using a T7/TNT in vitro translation kit as specified by the man-
ufacturer (Promega). COS-1-overexpressed proteins and P19 and ES cell nuclear
extracts were extracted with 2 binding buffer (25 mM HEPES [pH 7.9], 150
mM KCl, 0.4 mM EDTA, 2 mM dithiothreitol, 20% glycerol, 1 mM phenylmeth-
ylsulfonyl fluoride, 1 proteinase inhibitor cocktail [Roche]). The sequence of
the DR0 probe and electrophoretic mobility shift assay were performed by to
methods described previously (19). The sequence of PE1 was as follows: sense,
5GCATCCTGGCCATTCAAGGGTTGAGTACTTGTT 3; antisense, 5GCT
AAACAAGTACTCAACCCTTGAATGGGCCAGG 3 (928 to 919). The
sequence of PE2 was as follows: sense, 5CTAGGATTGTCCAAGCCAAGGC
CATTGTCCTGCCC 3; antisense, 5CTGAGGGCAGGACAATGGCCTTGG
CTTGGACAATC 3 (867 to 858).
Chromatin immunoprecipitation (ChIP) assay. Chromatin immunoprecipita-
tion ChIP assays were performed by the on-line protocol provided by the com-
pany Upstate. Undifferentiated and differentiated P19 and ES cells were treated
with 1% formaldehyde. Cross-linked DNA/protein was extracted and disrupted
by sonication. The recovered DNA was amplified with gene-specific primers. The
sequences of the primers surrounding the DR0 site in the Oct4 PP (from 127
to 95) are CCTCCGTCTGGAAGACACAGGCAGATAGCG for forward
and CGAAGTCTGAAGCCAGGTGTCCAGCCATGG for reverse; the se-
quence of the primers surrounding the PE1 and PE2 sites of the PE of the Oct4
gene (from 1000 to 824) are GCTGGGGAAGTCTTGTGTGA (forward)
and R:GCTTCCAGCCTAGTTCCTGG (reverse).
Northern blot analysis. Total RNAs from different time points of differenti-
ated P19 and ES cells were isolated using Trizole reagent (Invitrogen). Northern
blot analysis was performed as specified in protocol PT1190-1 (Clontech). Blots
were hybridized with 32P-labeled cDNAs corresponding to LRH-1 (bases 712 to
1296 [GenBank NM_030676]), Sox2 (bases 1239 to 1903, [GenBank U31967]),
Oct4 (bases 908 to 1260 [GenBank NM_013633]), FGF4 (bases 1 to 609 [Gen-
Bank NM_010202]), UTF1 (bases 324 to 918 [GenBank NM_009482]), and
REX1 (bases 461 to 2073 [GenBank NM_009556]). To ensure equal loading of
RNA samples, the blots were probed with radiolabeled cDNA corresponding to
the rat 18S rRNA (18S rRNA, bases 293 to 970 [GenBank X01117]).
Immunofluorescent and immunohistochemical staining. Collection of blasto-
cysts and immunofluorescent staining were performed by methods described
previously (24, 28). Female mice were superovulated by treatment with pregnant
mare serum gonadotropin and human chorionic gonadotropin, and the blasto-
cysts were flushed out of the uterus at E3.5 to 4.0. The zona pellucida of the
embryos was removed by brief exposure to Tyrode’s solution (pH 2.1 to 2.5)
(Irvine Scientific, Santa Ana, Calif.). The embryos were fixed with 4% parafor-
maldehyde and permeabilized by incubation with 0.2% Triton X-100 in phos-
phate-buffered saline (PBS). After being blocked in 10% donkey serum plus 2%
bovine serum albumin, the embryos were incubated with normal rabbit and goat
immunoglobulin G (IgG) or rabbit anti-LRH-1 antibody and goat anti-Oct4
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antibody in blocking buffer at 4°C overnight. They were then washed with PBS
and incubated with fluorescein isothiocyanate FITC-conjugated donkey anti-
rabbit IgG and Texas Red-conjugated donkey anti-goat IgG (Jackson Immuno-
Research Laboratories, Inc., West Grove, Pa.) and washed with PBS. They were
stained with 0.5 g of Hoechst 33258 (Sigma, St. Louis, Mo.) per ml and
mounted on glass slides with Vectashield mounting medium for fluorescence
(Vector Laboratories, Burlingame, Calif.) or kept in PBS buffer and examined
with an Axioskop 2 immunofluorescence microscope (Carl Zeiss).
The embryos at E6.5 were fixed in 10% formaldehyde in PBS and embedded
in parafilm. Antigens were unmasked by boiling the sections (7.5 m) and
treating them with 3% H2O2 and were blocked in 10% normal goat serum. An
immunostaining kit from Santa Cruz Biotechnology was used to detect the
LRH-1 or Oct4 protein. After being stained, the slides were counterstained in
0.05% methyl green to visualize histological structures.
Whole-mount and section in situ hybridization. Whole-mount in situ hybrid-
ization was carried out as described previously (19). The LRH-1 cDNA fragment
corresponding to nucleotides 1155 to 1540 and Oct4 cDNA (19) were labeled
with digoxigenin (Dig) (In vitro translation kit; Promega) as cRNA probes. E6.5
embryos were fixed in 4% paraformadehyde and embedded in paraffin. Sections
were probed with 35S-labeled sense or antisense cRNA probes against the
LRH-1 cDNA fragment.
Genotyping and identification of LRH-1/ embryos. The LRH-1/ mice
were purchased from Lexicon Genetics Inc. The accession number correspond-
ing to the OmniBank mice that were obtained is NM_030676. Genotypes of
weaned mice or embryos were determined by PCR analysis of tail-cut DNA
samples or yolk sacs. The primer set for the wild-type LRH-1 allele (forward F1,
5 TCTGCTAGTTTGGATACTGG 3; forward F2, 5 AAAGGACTGCCAAT
AATTTCGCT 3; reverse R1, 5 TTACAGAGTGAAGTTCCAGG 3; reverse
R2, 5 AAGTGGATCTCTGAGTCTGAG 3) was derived from the sequence of
the first exon and intron; the reverse primer for the mutant LRH-1 allele was the
same as that for the wild-type, and the forward primer (R4, 5 GCAGCGCAT
CGCCTTCTATC 3) was derived from the neo gene within the targeting vector.
Genomic DNA was extracted from tails of pups or from the yolk sacs of embryos
after E7.0, from the whole blastocysts after immunofluorescent staining, or from
scraped embryonic tissues from stained sections. Primers F1 plus R1 and R4
were used to genotype the pups, and the nested PCR strategy was used for
genotyping the blastocysts and scraped embryonic tissues.
Generation of LRH-1/ ES cells. LRH-1/ ES cells were generated by
deletion of exon 6 on both chromosomes, using a two-step targeting strategy (see
Fig. 7A). A mouse ES cell line was first generated in which loxP sites were placed
in the introns surrounding exon 6. ES cells that underwent homologous recom-
bination were selected with G418 and then transfected with a plasmid encoding
Cre recombinase; clones in which exon 6 and the neomycin resistance gene were
excised to allow selection for a second targeting event were identified by South-
ern blot analysis. These cells were then subjected to a second round of mutagen-
esis, using a targeting vector in which exon 6 was replaced by the neomycin
resistance gene, and were reselected with G418. Southern blot analysis identified
clones no longer containing a wild-type LRH-1 gene. The absence of LRH-1
transcript was verified by Northern blot analysis (see Fig. 7C).
Detection and display of LRH-1/SF-1 response elements in the mouse genome.
A set of 19 LRH-1/SF-1 responses elements (LRE) was collected from the
published data (see Table 1). These sites were used to train a hidden Markov
model (HMM) using HMMER v.2.32 by Eddy (14). All mouse chromosomes
were scanned using the HMM with an expected value cutoff set to 0.01, and the
chromosomal coordinates of the resulting hits were saved. The chromosomal
locations of genes of interest were taken from the KnownGenes tables of the
UCSC Genome Browser database (26). The LREs were visualized by uploading
the list of hits to the UCSC Genome Browser (27), using the “custom tracks”
feature (see Fig. 2A).
RESULTS
Expression of LRH-1 in ES cells. To investigate whether
LRH-1 regulates Oct4 expression during early embryonic de-
velopment, we compared LRH-1 and SF-1 expression patterns
in ES cells and P19 cells by Northern analysis (Fig. 1). As
previously shown, SF-1 was coexpressed with Oct4 in undiffer-
entiated P19 cells and expression of both genes decreased
during differentiation (19). LRH-1 was not expressed in P19
cells. In contrast, LRH-1 and Oct4 were coexpressed in undif-
ferentiated ES cells whereas SF-1 was not (Fig. 1). Expression
of LRH-1 decreased to undetectable levels in ES cells after
12 h of RA treatment. The expression of Oct4 also decreased
with RA treatment and was almost undetectable after 36 h of
RA treatment. Thus, Northern blot analysis showed that SF-1
is selectively expressed in P19 cells and LRH-1 is expressed in
ES cells (Fig. 1). The concomitant expression pattern of LRH-1
and Oct4 in ES cells suggested that LRH-1 might regulate Oct4
expression.
Direct binding of LRH-1 to the Oct4 PE and PP. It was
reported that there are two SF-1 response elements in the Oct4
promoter: DR0 (AGGTCAAGGCTA [from 42 to 31]) and
the SF1 site in the Oct4 PP region (5, 19). Expression of Oct4
at the epiblast stage is regulated by the proximal enhancer in
addition to the proximal promoter (31, 56). Therefore, we
searched the Oct4 promoter for additional SF1/LRH-1 re-
sponse elements. To do this, we generated a matrix of known
LRH-1-binding sites (Table 1) from which a Hidden Markov
Model was generated using HMMER and used to search the
entire mouse genome. This search identified six LRH-1 bind-
ing sites. Site 1 is in a nonconserved region outside the prox-
imal enhancer. Two sites, 2 and 3, are located in the evolu-
FIG. 1. Northern blot analysis of SF1, LRH-1, and Oct4 expression in P19 and ES cells at different time points of RA-induced differentiation.
The numbers above the figures indicate the RA (1 M) treatment time (hours). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an
internal control for loading and RNA integrity.
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tionally conserved region (CR2) that corresponds to the Oct4
PE. Sites 4 and 5 (site 5 corresponds to SF1 site in reference
5) are in a moderately conserved region, and site 6 is the DR0
element in a highly conserved region (CR1) of the (PP) (Fig.
2A).
To address the function of LRH-1 in the regulation of Oct4
expression, we tested the ability of LRH-1 protein to bind to
these predicted response elements. We focused on the LRH-
1-binding sites in the evolutionarily conserved region, sites 2, 3
and 6, which were termed PE1, PE2, and DR0, respectively.
The binding of SF-1 and LRH-1 to the PE1, PE2, and DR0
sites was confirmed by supershift analysis (Fig. 2B). Both SF-1
and LRH-1 bound with high affinity to the DR0 and PE2
probes and weakly to the PE1 probe. The anti-SF-1 antibody
disrupted the binding of COS1-overexpressed SF-1 proteins
with the probes (lanes 2, 6, and 10). The anti-LRH-1 antibody
supershifted the binding complex generated by LRH-1 protein
(lanes 4, 8, and 12). To detect endogenous LRH-1 DNA-
binding activity, we extracted nuclear proteins from undiffer-
entiated ES cells or cells that had been treated with RA for
36 h, and electrophoretic mobility shift assay was performed. A
fast-migrating complex appeared when nuclear extracts from
undifferentiated ES cells were used; this complex was lost when
RA-differentiated cell extracts were used (Fig. 2C). LRH-1
antibodies supershifted the complex in ES cells (lane 5), but
SF-1 antibodies did not (lane 4). The antibody supershift re-
sults agreed with the LRH-1 expression results for ES cells
using Northern analysis (Fig. 1). As previously reported (19,
20), a transient retinoid acid induced factor complex formed
with the Oct4 DR0 probe in extracts from differentiated P19
cells; a complex with similar mobility was detected using ex-
tracts prepared from differentiated ES cells (Fig. 2C, lane 2).
To demonstrate binding of endogenous LRH-1 to the Oct4
promoter in ES cells, ChIP was employed. The results of ChIP
analysis demonstrated direct binding of LRH-1 to the Oct4 PE
and PP in vivo (Fig. 2D). Using Oct4 PP- and PE-specific ChIP
primers, strong PCR-amplified signals were generated from
undifferentiated ES cell DNA coimmunoprecipitated with an-
ti- LRH-1 antibodies, demonstrating that LRH-1 binds to
these two regions of the Oct4 promoter in vivo. Similar binding
activities were observed in P19 cells with anti-SF-1 antibodies
but not anti-LRH-1 antibodies. Binding of LRH-1 and SF-1
decreased on RA-induced differentiation in ES cells and P19
cells, respectively. This DNA-binding pattern is consistent with
the expression profiles of SF-1 and LRH-1 in P19 and ES cells
(Fig. 1). These results clearly demonstrate that endogenous
LRH-1 in undifferentiated ES cells is directly bound to the
Oct4 PP and PE in vivo and support a role for LRH-1 in the
regulation of Oct4 expression in ES cells.
LRH-1 activation of Oct4 through the PE and PP. To deter-
mine whether LRH-1 can regulate expression of the Oct4 gene,
a set of luciferase reporters was constructed as illustrated in
Fig. 3A and described in Materials and Methods. The various
Oct4 luciferase reporter constructs were transfected into un-
differentiated and differentiated P19 cells. Insertion of the
Oct4 PE upstream of the PP enhanced reporter activity about
fivefold in undifferentiated P19 cells (Fig. 3B). When the LRH-
1-binding site in the PP was mutated (PP*), the PE enhancer
activity was lost in P19 cells (Fig. 3B). Regulation by the Oct4
PE could be bestowed on a heterologous promoter since a
similar effect was seen when the PE was placed before the
simian virus 40 (SV40) basic promoter (Fig. 3B). In RA-dif-
ferentiated P19 cells, the PE had no enhancer activity in either
the wild-type context of the Oct4 promoter or linked to the
SV40 promoter (Fig. 3B). These results show that transcription
factors present in undifferentiated P19 cells but not in differ-
entiated P19 cells (i.e., SF-1) act on the Oct4 PE.
To further address the function of SF-1 and LRH-1 on the
PE enhancer, we cotransfected SF-1 and LRH-1 expression
vectors with the different Oct4 luciferase reporters in RA-
treated P19 cells (Fig. 3C). The transfection results showed
that SF-1 and LRH-1 increased the PP and PE-PP reporter
activities fourfold whereas SF-1 and LRH-1 had no effect on
the mutated PP* and PE-PP* reporter activities. Regulation of
a heterologous reporter by SF-1 and LRH-1 could be bestowed
by introduction of the PE into the SV40 promoter. Transfected
SF-1 and LRH-1 had no activity on the control SV40 promoter
but produced twofold activation of the PE-SV40 reporter.
These in vitro results demonstrated that endogenous SF-1 and
transfected SF-1 or LRH-1 in P19 cells can activate reporter
activity through the proximal enhancer of the Oct4 gene by
binding to elements in the PE; such activation is dependent on
the proximal promoter.
LRH-1 expression during early murine embryonic develop-
ment. To investigate the physiological relevance of LRH-1 to
the regulation of Oct4 expression in vivo, we examined the
expression pattern of LRH-1 in mouse embryos at early devel-
opmental stages when the Oct4 gene is expressed. Using LRH-
1-specific antibodies generated against the N-terminal 100
amino acids of mouse LRH-1, the inner cell mass (ICM) and
primitive endoderm of the blastocyst (E3.5 to E4.0) were spe-
cifically immunostained; the trophectoderm layer and blasto-
coelic cavity were only weakly stained (Fig. 4A, panel g). No
staining was seen in experiments performed with control pre-
immune IgG (panel c). At this stage, Oct4 is also strongly
expressed in the ICM and primitive endoderm (32) (panel h).
The expression pattern of LRH-1 protein in the blastocyst was
identical to that of -galactosidase staining in a previously
reported LRH-1:lacZ knockout mouse model (39). The expres-
TABLE 1. List of published LRH-1 response elements
Gene Bindingelements Species Reference




Hepatic nuclear factor 1 (HNF1) CCAAGGTTC Mouse 8
Hepatic nuclear factor 3 (HNF3) TCAAGGTTA Mouse 40
3--Hydroxysteroid dehydrogenase TCAAGGTTC Human 41
(3-HSD) ACAAGGACA Human
Cytochrome P450 19 (Cyp19) CCAAGGTCA Human 23
TCAAGGGCA Human
TCAAGGGCG Mouse
Carboxyl ester lipase (CEL) CCAAGGTCA Human 17
Cytochrome P450 7A1 (Cyp7A1) TCAAGGCCA Human 34
TCAAGGCCG Rabbit
TCAAGGCTG Hamster
Cytochrome P450 8B1 (Cyp8B1) GCAAGGTCC Rabbit 55
CCAAGGGCA Rabbit




Phospholipase A2 (PLA-2) TCAAGGCTG Mouse 3
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FIG. 2. Direct binding of SF-1/LRH-1 to the Oct4 proximal enhancer and promoter. (A) Localization of the LRH-1- binding sites, PE1, PE2,
and DR0 elements in the Oct4 proximal enhancer and promoter. The SF-1/LRH-1-binding sites were identified by HMMER and labeled as black
bars in the mouse Oct4 gene. The relative conservation between the mouse and human Oct4 gene derived from the UCSC genome browser was
plotted as the gray curve. Arrows indicate the three regulatory regions DE, PE, and PP. The highly conserved regions CR1, 2, 3 and 4 are depicted
as open boxes. The LRH-1- binding sites PE1, PE2, and DR0 that were tested are shown as black bars in CR2 and CR1. (B) COS1-overexpressed
SF-1 and LRH-1 binding to the PE1, PE2, and DR0 probes in the absence or presence of antibodies. (C) Total proteins extracted from
undifferentiated or differentiated ES cells were incubated with DR0 probe in the absence or presence of LRH-1 or SF-1 antibodies. The
arrowheads mark the SF-1- and LRH-1-binding activity. Five-point stars mark the position of antibody-supershifted binding signal, and four-point
stars mark the GCNF TRIF complex binding to the DR0. (D) ChIP analysis of direct binding of endogenous SF-1 and LRH-1 to the Oct4 PE and
PP in vivo. Cross-linked genomic DNA from RA-differentiated P19 and ES cells was immunoprecipitated with anti-LRH-1 or anti-SF-1 antibody
or preimmune serum IgG and amplified with Oct4 PP and PE specific primers.
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sion of LRH-1 in embryos from E6.5 to E7.5 was detected by
whole-mount in situ hybridization with Dig-labeled LRH-1
cRNA probe. At the advanced egg cylinder stage (E6.5 to
E7.0), LRH-1 mRNA was detected throughout the embryonic
and extraembryonic regions, including the visceral endoderm
and embryonic ectoderm (Fig. 3B, panel a). During the early
primitive streak stage embryo (E7.5), LRH-1 mRNA was still
expressed throughout the embryo (Fig. 4B, panel b). There are
conflicting reports of LRH-1 expression in the embryonic ec-
toderm (39, 45). Therefore, to confirm that LRH-1 was ex-
pressed in the epiblast and to demonstrate coexpression of
LRH-1 and Oct4 proteins in the embryonic ectoderm, embryos
at E6.5 to E7.0 were dissected and hybridized with cRNA
probe against LRH-1 cDNA and immunostained with anti-
LRH-1 and anti-Oct4 antibodies. Results from section in situ
showed that LRH-1 was expressed throughout the entire em-
bryo at E6.5 including the embryonic and extraembryonic cell
layers (Fig. 4C). Consistent with the in situ results, LRH-1
FIG. 3. Activation of the Oct4 PE and PP by SF-1 and LRH-1. (A) Illustration of the Oct4 PE and PP luciferase reporter constructs.
(B) Activation of the Oct4 PE-luciferase reporters in the P19 cells and loss of the Oct4 PE-luciferase reporter activation in RA-differentiated P19
cells. (C) Activation of the Oct4 PE-luciferase reporters in differentiated P19 cells by transiently transfected SF-1 and LRH-1 expression vectors
(200 ng/well). Relative fold activation of the PE was calculated by dividing by the activity of corresponding luciferase reporter activity in the absence
of the PE, which was set at 1. Relative activation by transfected SF-1 or LRH-1 was calculated by dividing by the activity of corresponding luciferase
reporter activity in the absence of SF-1 and LRH-1, which was set at 1. Results represent the mean and standard deviation of data from triplicate
experiments.
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protein was detected throughout the embryo, including the
visceral endoderm, embryonic ectoderm, and the extraembry-
onic region (Fig. 4D, panel b). Oct4 was specifically located in
the ectoderm of the epiblast (panel c). Thus, the LRH-1 gene
is coexpressed with the Oct4 gene in the ICM and epiblast
during early developmental stages.
Disruption of LRH-1 gene expression leads to embryonic
death. The in vitro and in vivo results suggested that LRH-1
probably plays a key role in regulating Oct4 expression during
early embryonic development. To further understand the reg-
ulation of Oct4 expression by LRH-1 in vivo, the LRH-1 gene
was disrupted by gene targeting. Disruption of the LRH-1 gene
was undertaken by insertion of the -geo cassette into the first
exon of LRH-1 gene via homologous recombination in ES cells
(Fig. 5A) (54). Southern blot and PCR analysis demonstrated
the insertion of the -geo gene (Fig. 5B and C). A cDNA probe
that spanned exons 6 to 9, encoding the ligand-binding domain,
was used as probe to detect LRH-1 mRNA in mutant embryos.
LRH-1 mRNA was present in wild-type E6.5 to E7.0 embryos
but not in LRH-1/ embryos, demonstrating that the LRH-1
gene was successfully disrupted (Fig. 5D) through the replace-
ment of the first exon with the -geo gene. The genotype of the
embryos was further confirmed by genomic PCR analysis.
Breeding results showed that matings of heterozygous off-
spring failed to produce pups homozygous for the mutant
LRH-1 allele. In total, 248 pups were genotyped (Table 2); 119
of the mice were wild type and 129 were heterozygous, but no
homozygous pups were detected. These data confirm previous
data that disruption of the LRH-1 gene causes embryonic
lethality (13, 15, 39). The lower ratio (1.1:1) of LRH-1/ to
wild-type pups (expected 2:1 based on Mendelian genetics)
indicates haploinsufficiency (13). To determine precisely when
homozygous LRH-1 mutants die, timed-mated heterozygous
females were sacrificed at different gestational stages and the
blastocysts or embryos were genotyped by PCR analysis (Table
2). LRH-1/ blastocysts were found at E3.5 to E4.0 at a
wild-type/heterozygote/homozygote ratio of 23:42:21, which is
close to the expected Mendelian ratio of 1:2:1. The LRH-1/
blastocysts appeared morphologically normal (Fig. 6A, panel
i). Mutant embryos were also found at E6.5 to E7.0, but the
ratio (12%) was much lower than expected. No LRH-1/
embryos were detected at E7.5 to E9.5. These data demon-
strate that LRH-1/ embryos die around E6.5.
Loss of Oct4 expression in the LRH-1/ embryos. The
activation of Oct4 reporters by LRH-1 and the early embryonic
death of the LRH-1/ embryos led us to examine Oct4 ex-
pression in the LRH-1/ embryos. Analysis of Oct4 expres-
sion showed a strong signal in the ICM of blastocysts at E3.5 to
E4.0 and epiblast of wild-type embryos at E6.5 (Fig. 4 and 6).
Oct4 was expressed in the ICM (Fig. 6A, panels h and l) in the
LRH-1/ or LRH-1/ blastocysts even though the LRH-1
staining signal was weak (panel g) or absent (panel k), respec-
tively. However, at E6.5 to E7.0, Oct4 mRNA was undetectable
in epiblasts of LRH-1/ embryos (Fig. 6B, panels c and d).
The mutant embryos were much smaller than the wild-type
controls. Further analysis revealed that histologic abnormali-
ties in LRH-1/ embryos were apparent as early as E6.5 to
E7.0 (Fig. 6C). At this stage, the extraembryonic and embry-
onic tissues in wild-type embryos were clearly distinguished
from each other (Fig. 6C, panels a to c); in contrast, they were
FIG. 4. Expression of LRH-1 in early mouse embryonic develop-
ment. (A) Immunofluorescent detection of LRH-1 and Oct4 proteins
in blastocysts. DNA in blastocysts was stained with Hoechst 33258 and
appears blue (panels b and f), whereas LRH-1 protein stained green
with a fluorescein isothiocyanate conjugate (g) and Oct4 appeared red
after staining with Texas Red conjugates (h). At least 30 blastocysts
from more than three wild-type mice were stained. (B) Whole-mount
in situ hybridization of embryos at E6.5 to E7.0 and E7.5 with Dig-
labeled antisense LRH-1 cRNA probe. (C) In situ hybridization with
sagittal sections of mouse E6.5 embryos and surrounding deciduas
performed with sense and antisense 35S-labeled LRH-1 RNA probe.
(D) Immunohistochemical detection of LRH-1 and Oct4 proteins in
sagittal sections of mouse embryos on day E6.5 with preimmune IgG
(a), anti-LRH-1 antibody (b), and anti-Oct4 antibody (c). bc, blasto-
coel; eec, embryonic ectoderm; em, embryonic mesoderm; ex, ex-
traembryo; exec, extraembryonic ectoderm; exed, extraembryonic
endoderm; exem, extraembryonic mesoderm; pe, primitive endoderm;
tp, trophectoderm; ved, visceral endoderm.
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difficult to distinguish in the LRH-1/ embryos (panels d to f).
Moreover, in LRH-1/ embryos, the visceral endoderm was
expanded and the cells were loosely arranged; the embryonic
ectoderm showed a marked disorganization, and the proamni-
otic cavity was malformed. The loss of Oct4 expression in the
epiblast of LRH-1/ embryos was further confirmed by im-
munohistochemical staining (panel f). These results indicated
that LRH-1 is not required to maintain the expression of the
FIG. 5. Loss of LRH-1 expression in LRH-1/ embryos. (A) LRH-1 gene-targeting strategy. Approximately 20 kb of the LRH-1 locus is shown.
The KpnI restriction sites are labeled (K). The first exon, which was disrupted, contains the LRH-1 ATG start codon (depicted as a solid box).
The targeting vector pKOS51 with homologous arms and the lacZ and neo genes are shown relative to the genomic structure. The first exon of
the recombinant allele was disrupted by the insertion of the -geo gene. (B) Southern blot analysis was used to genotype the ES cell clones by using
a 5probe upstream of the targeting vector. Digestion with KpnI yielded a 15-kb band for the wild-type allele and a 10.5-kb band for the targeted
allele. The clone 2B5 was injected into recipient blastocysts. (C) Genotyping of the offspring by genomic PCR with primers F1 plus R1 and R4
produced a 350-bp wild-type fragment and 490-bp neo DNA fragment. (D) Analysis of LRH-1 expression in LRH-1/ embryos at E6.5-7.0 by
whole-mount in situ hybridization with an LRH-1 cRNA probe showed complete loss of LRH-1 expression in LRH-1/ embryos.
TABLE 2. Targeted disruption of the LRH-1 gene leads to
embryonic death
Age
No. (%) of deaths in:
/ mice / mice / mice
Pups 119 (48%) 129 (52%) 0
E3.5–E4.0 23 (27%) 42 (49%) 21 (24%)
E6.5 31 (33%) 51 (55%) 11 (12%)
E7.5 4 10 0
E8.5 3 6 0
E9.5 1 5 0
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FIG. 6. Analysis of Oct4 expression in embryos on days E3.5 to E7.0 from LRH-1/ intercrosses. (A) Immunofluorescent detection of LRH-1
and Oct4 proteins in blastocysts (E3.5 to E4.0) with anti-LRH-1 and anti-Oct4 antibodies. About 90 blastocysts flushed from six heterozygous
females were stained and genotyped. (B) Whole-mount in situ analysis of Oct4 mRNA in the embryos at E6.5 to E7.0 with a Dig-labeled Oct4 RNA
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Oct4 gene in the ICM but is required to maintain its expression
in the epiblast of developing embryos.
Rapid down-regulation of Oct4 expression in differentiating
LRH-1/ ES cells. To determine if the effects of loss of
LRH-1 on Oct4 expression were cell autonomous, an LRH-
1/ ES cell line was established. Due to the inability to gen-
erate LRH-1/ ES cell lines from blastocyst outgrowths from
our LRH-1 knockout mice, a sequential knockout strategy
using two different targeting vectors was used in which exon 6,
which encodes the T-box region of the DNA-binding domain
and part of the hinge region, was disrupted in both LRH-1
alleles (Fig. 7A). Southern blot analysis confirmed deletions in
both LRH-1 alleles (Fig. 7B). As expected, Northern blot anal-
ysis of the LRH-1/ ES cells failed to detect LRH-1 mRNA in
these cells (Fig. 7C). Monolayer cultures of LRH-1/ and
LRH-1/ ES cells were induced to differentiate for 4, 8, and
12 days by withdrawal of LIF. No RA was added to the ES cell
cultures, so that the kinetics of Oct4 repression was slower
(comparing Fig. 1A with 6C). No differences were seen in the
number or morphology of wild-type and knockout cells during
differentiation (data not shown).
Expression of Oct4 was compared in wild-type and LRH-
1/ ES cells induced to differentiate for 4, 8, and 12 days.
Oct4 expression decreased much more rapidly in LRH-1/ ES
cells than in wild-type cells (Fig. 6C). LRH-1 expression was
lost and the expression of Oct4 decreased more rapidly in the
mutant ES cells than in differentiating wild-type ES cells. Ex-
pression of Sox2, FGF4, UTF1, and REX1, which are depen-
dent on Oct4 (1, 7, 33, 52), were maintained in wild-type ES
cells but dropped in LRH-1/ ES cells after removal of LIF
(Fig. 6C). Thus, in the absence of LRH-1, there is a failure to
maintain Oct4 expression with a concomitant loss of expression
of genes involved in maintaining pluripotence in ES cells.
DISCUSSION
In contrast to lower organisms, segregation of the mamma-
lian germ cell lineage occurs relatively late during embryonic
development as the embryo gastrulates. To facilitate this novel
evolutionary mechanism, pluripotence must be maintained in
all cells prior to this stage to allow segregation of the pluripo-
tent cells destined to become primordial germ cells. To achieve
this goal, two extraordinary events have to occur. One is that
pluripotence has to be maintained as the embryo proper ex-
pands from an ICM to the epiblast. Oct4 is an essential tran-
scription factor that regulates pluripotence, and thus its ex-
pression has to be maintained in the epiblast in the face of
burgeoning signals to differentiate and pattern the embryo.
Second, Oct4 expression has to be susceptible to repression in
cells destined to become somatic cells and maintained in the
small population that are destined to become PGCs. It is
known that two enhancers in the Oct4 promoter regulate cell-
specific expression of the Oct4 gene (31, 56). However, little is
known about the transcription factors that specifically regulate
Oct4 gene expression in different cell types or at different
developmental stages. In this study, we demonstrate that
LRH-1 can regulate Oct4 expression in ES cells and is required
to maintain its expression at the epiblast stage of mouse em-
bryonic development.
Complementary expression and function of SF-1 and LRH-1
in P19 and ES cells. Based on work with P19 cells, it was
previously hypothesized that the orphan receptor SF-1 regu-
lates Oct4 expression. However, the survival of SF-1 knockout
mice till birth demonstrates that SF-1 is not a key factor in the
maintenance of Oct4 expression during early embryonic devel-
opment (30). Expression of SF-1 in P19 cells appears to be a
quirk of their derivation. ES and P19 cells are derived from
different embryonic developmental stages: the former is a non-
tumor cell line derived from blastocyst ICM (about E4.5),
whereas the latter is a teratocarcinoma cell line derived from
transplanted epiblast stage cells at E7.5 (10, 53). P19 cells are
considered a representative cell system to study events that
occur during gastrulation stages of embryonic development.
Unlike P19 cells, ES cells do not express SF-1 but do express
LRH-1 (Fig. 1 and 2C and D), which more faithfully reflects
the in vivo situation in mouse embryos (10). Thus, LRH-1 and
not SF-1 regulates Oct4 expression during early embryonic
development.
Regulation of Oct4 expression. Despite its crucial role in
development and maintenance of the germ cell lineage, rela-
tively little is known about how the Oct4 gene is regulated. The
cis regulation of Oct4 expression throughout the pluripotent
life cycle has been defined using a LacZ transgenic reporter
system (56). Three important regulatory regions were defined
in the Oct4 promoter by this study: the PP element and the PE
and DE. The transgenic analysis established that the DE is
essential for the expression of Oct4 in all stages of the pluri-
potent life cycle except the epiblast stage, when Oct4 expres-
sion is regulated by the proximal enhancer. The proximal pro-
moter is essential for Oct4 expression at all stages of the
pluripotent life cycle. There are likely to be several important
transcription factors binding to each of these elements at dif-
ferent stages. To date the Sp factors Sp1 and Sp3 and several
nuclear receptors, including retinoid receptors and the orphan
receptors COUP-TF and SF-1, have been implicated in the
regulation of Oct4 expression (5, 6, 31, 42, 51). However, KO
mouse models have not substantiated a functional link be-
tween any of these factors and regulation of Oct4 expression.
In contrast, the orphan receptor GCNF binds to the DR0
element in the PP and regulates Oct4 expression. The func-
tional consequence of inactivation of the GCNF gene is loss of
proper repression of the Oct4 gene in somatic cells at gastru-
lation (19).
In this study we established that the orphan nuclear receptor
LRH-1 also regulates Oct4 expression by binding to elements
in the PP and PE. The consequence of inactivation of the
probe. Panels a to d shows four individual embryos. (C) Histology and Oct4 protein analysis in E6.5 to E7.0 embryos. LRH-1/ (a to c) and
LRH-1/ embryos (d to f) were dissected, and the sections were stained with hemotoxylin and eosin (a, b, d, and e) or immunostained with
anti-Oct4 antibody and counterstained with methyl green (c and f). After staining, blastocysts were recovered or embryonic tissue was scraped off
the sections for genotyping. ec, exocoelomic cavity; eec, embryonic ectoderm; em, embryonic mesoderm exec, extraembryonic ectoderm; exed,
extraembryonic endoderm; exem, extraembryonic mesoderm; pac, proamniotic cavity; ved, visceral endoderm.
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FIG. 7. Loss of Oct4 gene expression in LRH-1/ ES cells. (A) Schematic representation of the two-step targeting strategy to inactivate the
LRH-1 gene in ES cells. The schematic shows exons 4 to 7 of the LRH-1 gene, the two targeting vectors, and the two disrupted LRH-1 alleles. Solid
boxes indicate exons, and solid arrows indicate the PGK-tk and PGK-neo cassettes. Selected restriction enzyme sites are indicated. After disruption
of the first LRH-1 allele, the neo cassette was excised with Cre recombinase prior to targeted disruption of the second LRH-1 allele. The second
targeting vector did not contain lox P sites. (B) Southern blot analysis of HindIII-digested DNA with the indicated probe. The wild-type allele yields
a 17.7-kb fragment, the first targeted LRH-1 allele yields a 14.3-kb fragment, and the second targeted LRH-1 allele yields 4.6 kb on HindIII
digestion. (C) Loss of expression of the Oct4 gene and other pluripotency factors in differentiated LRH-1/ ES cells. Northern blot analyses of
the indicated genes were performed with RNA prepared from LRH-1/ or LRH-1/ ES cells differentiated for 0, 4, 8, or 12 days by withdrawal
of LIF.
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LRH-1 gene is loss of Oct4 expression at the epiblast stage of
development. The requirement of LRH-1 to maintain Oct4
expression in ES cells of the epiblast correlates directly with
the requirement for the elements to which it binds for epiblast
expression (56). Phylogenetic comparison of the sequence of
the Oct4 promoter shows that the elements regulating Oct4
expression are conserved across species (38). Importantly, the
conservation of the DR0, PE1, and PE2 sequences between
mice and humans suggests that LRH-1 probably will play an
essential role in regulating human Oct4 expression in differen-
tiating ES cells and embryonic development.
Developmental roles of LRH-1. The broad expression of
LRH-1 during embryonic development suggests that it proba-
bly likely impact multiple developmental processes (17). Be-
langer’s group generated an LRH-1:lacZ knock in reporter
allele and observed -galactosidase staining in heterozygous
morulae and blastocysts (39). We have confirmed the expres-
sion of LRH-1 protein in the ICM of blastocysts. It was re-
ported that LRH-1 mRNA was detectable only in the visceral
endoderm and not in the embryonic ectoderm from E5.5 to
E6.5 (39). In our experiments, LRH-1 mRNA and protein are
clearly detectable throughout the entire embryo at E6.5 (Fig.
4). This discrepancy may be due to the use of different detec-
tion systems. Unfortunately, we were unable to detect the
expression of the lacZ reporter gene in our -geo knock-in
allele. This is due to deletion of 70 bp upstream of the LRH-1
ATG initiation codon caused by the insertion of the -geo
gene, which disrupts LRH-1 and LacZ reporter expression.
Inactivation of the LRH-1 gene results in embryonic lethality
at a later stage than in Oct4 mutant embryos, which die on day
E5.5 lacking an ICM as the morula differentiated along the
trophectodermal lineage (32). This suggests that LRH-1 is not
required to maintain Oct4 expression in the ICM of blastocysts
but, rather, is required to maintain its expression in the epi-
blast. Consistent with the results obtained in the embryo, Oct4
expression is maintained in undifferentiated LRH-1/ ES
cells. LRH-1 may not play a significant role in early preimplan-
tation development. Its expression in the zygote and morula
may simply represent expression of the factor before the time
when it is required to maintain Oct4 expression.
The LRH-1 expression pattern at later embryonic stages
supports a role for LRH-1 in regulating endodermal develop-
ment and expression of endodermal genes, such as -fetopro-
tein, HNF1, HNF3, and HNF4 during early hepatic and
pancreatic development (2, 29, 39, 40, 49). Likewise, LRH-1
may regulate these genes in the visceral endoderm. It was
previously reported that inactivation of the LRH-1 gene leads
to defective visceral endoderm development (39). Thus, there
are likely to be multiple defects in the LRH-1/ embryos that
contribute to embryonic lethality.
Role of LRH-1 in ES cells. Several pluripotency factors in
addition to Oct4, including Sox2, FGF4, UTF1, and REX1, are
more rapidly down-regulated upon withdrawal of LIF in the
LRH-1/ ES cell line than in wild-type ES cells. Previous
studies showed that Oct4 functions alone or as a complex with
other factors to regulate the expression of these genes (1, 7, 33,
52). Northern analysis of the wild-type ES cells showed that
although Oct4 expression was decreased along with LRH-1
levels after withdrawal of LIF, expression of Sox2, FGF4,
UTF1, and REX1 was maintained. These data suggest that
there is adequate Oct4 to maintain their expression. However,
in LRH-1/ ES cells, a more rapid loss of Oct4 expression
coincided with decreased expression of Sox2, FGF4, UTF1, and
REX1. The decreased expression of these genes is unlikely to
be a direct consequence of the absence of LRH-1, since no
LRH-1-binding sites have been identified in their promoters.
Decreased expression of Sox2, FGF4, UTF1, and REX1 is not
a generalized, nonspecific effect due to unhealthy ES cells,
since most genes are expressed normally as measured by mi-
croarray analysis (data not shown). The early stages of ES cell
FIG. 8. Reciprocal regulatory model for Oct4 expression by the orphan nuclear receptors LRH-1 and GCNF during early embryonic
development. Oct4 is expressed in the ICM and epiblast (EP) and restricted to the primordial germ cells (PGC) after gastrulation. LRH-1
maintains Oct4 gene expression in the epiblast and early differentiated ES cells by direct binding to the PE and PP. After gastrulation, GCNF
replaces LRH-1, binds to the PP, and represses Oct4 gene expression in somatic cells. Unknown factors (X) regulate the expression of Oct4 in the
blastocyst and PGCs through the DE and PP. TP: trophectoderm; PE: primitive ectoderm; PC: proamnion cavity; EX: extraembryo; EP epiblast;
PGC: primordial germ cell; VED: visceral endoderm.
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differentiation probably approximate what is occurring in the
epiblast in that pluripotence must be maintained even in the
presence of nascent differentiation signals.
Maintenance of Oct4 expression is unlikely to be the only
role of LRH-1 in regulating ES cell function. In addition to
pluripotence, another property of ES cells is a high prolifera-
tive capacity. LRH-1 plays an important role in regulating
proliferation through regulation of cyclin G1 expression (9).
Interestingly it was found that LRH-1 and -catenin synergis-
tically regulate intestinal cell proliferation through cyclin G1
(9). Inactivation of the -catenin gene is lethal to the embryo
at the same stage as LRH-1 and presents a similar phenotype
(25). Thus, LRH-1 and -catenin may cooperate to regulate
ES cell proliferation and expansion from an ICM to an epi-
blast.
Novel regulatory switch for Oct4 expression. Based on our
findings in this study and our previous studies, we propose a
novel regulatory switch for Oct4 gene expression during ES cell
differentiation and early embryonic development (Fig. 8).
LRH-1 activates or maintains Oct4 gene expression in the
epiblast of mouse embryos and undifferentiated ES cells.
Maintenance of Oct4 expression by LRH-1 is mediated
through binding to LRH-1 elements in the proximal enhancer
and promoter. Upon differentiation of ES cells or gastrulation
of embryos, GCNF expression is induced and LRH-1 is down-
regulated, leading to the replacement of LRH-1 by GCNF at
the Oct4 promoter. This switch in transcription factors blocks
the DR0 in the proximal promoter and represses Oct4 gene
expression in somatic cells. In the ICM and primordial germ
cells, other transcription factors (X) bind to the distal enhancer
and proximal promoter to maintain Oct4 expression. The re-
ciprocal regulation of Oct4 by GCNF and LRH-1 through
binding to common sequence elements has profound implica-
tions for the maintenance of pluripotence and differentiation
of ES cells. Both LRH-1 and GCNF are orphan nuclear re-
ceptors that may be regulated by ligands, which provides an-
other potential mechanism for regulating pluripotency in ES
cells. The demonstration that LRH-1 is required to maintain
Oct4 expression in the epiblast of mouse embryos opens a new
window to view ES cell maintenance, pluripotence, and differ-
entiation and a new target with which to manipulate these
processes.
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